Biotrade Recommends Consumers Stop Consumption of U-Dream Product Immediately

Saturday, December 21, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

VICTORIA, Dec. 20, 2019 /CNW/ - On December 17th, Health Canada formally indicated that they have found "Zopiclone impurity 22" in some batches of the U-Dream product. This is not the same as Zopiclone, a known pharmaceutical sleep aid (it is a similar molecule). Health Canada has confirmed that Zopiclone is not present in the product.

Biotrade Canada is in the process of conducting independent testing. As Health Canada has not given any indication regarding the amounts of the impurity detected, Biotrade recommends consumers stop using U-Dream products. More information can be found at www.udreamherbal.com or 250.733.2028.

As of November 21st, based on an initial concern raised by Health Canada, Biotrade Canada immediately stopped distribution and informed retailers to pull the product from store shelves and to stop selling.

SOURCE Biotrade Canada Ltd.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store